Free Trial
NASDAQ:AKYA

Akoya Biosciences (AKYA) Stock Price, News & Analysis

Akoya Biosciences logo
$1.29 0.00 (0.00%)
As of 07/8/2025

About Akoya Biosciences Stock (NASDAQ:AKYA)

Key Stats

Today's Range
$1.29
$1.29
50-Day Range
$1.12
$1.37
52-Week Range
$0.93
$3.42
Volume
N/A
Average Volume
416,191 shs
Market Capitalization
$64.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.51
Consensus Rating
Hold

Company Overview

Receive AKYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akoya Biosciences and its competitors with MarketBeat's FREE daily newsletter.

AKYA Stock News Headlines

AKYA Akoya Biosciences, Inc. - Seeking Alpha
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.
See More Headlines

AKYA Stock Analysis - Frequently Asked Questions

Akoya Biosciences' stock was trading at $2.29 at the beginning of the year. Since then, AKYA shares have decreased by 43.7% and is now trading at $1.29.

Akoya Biosciences, Inc. (NASDAQ:AKYA) released its quarterly earnings results on Monday, May, 12th. The company reported ($0.32) earnings per share for the quarter, missing the consensus estimate of ($0.29) by $0.03. The firm earned $16.64 million during the quarter, compared to the consensus estimate of $20.19 million. Akoya Biosciences had a negative trailing twelve-month return on equity of 487.85% and a negative net margin of 59.44%.

Akoya Biosciences (AKYA) raised $125 million in an IPO on Friday, April 16th 2021. The company issued 6,600,000 shares at a price of $18.00-$20.00 per share. J.P. Morgan, Morgan Stanley, Piper Sandler and Canaccord Genuity served as the underwriters for the IPO.

Top institutional shareholders of Akoya Biosciences include Vanguard Personalized Indexing Management LLC (0.06%). Insiders that own company stock include Matthew Winkler, Garry PhD Nolan, Brian Mckelligon, John Frederick Ek, Frederic Pla and Joseph Driscoll.
View institutional ownership trends
.

Shares of AKYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akoya Biosciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Broadcom (AVGO), Invesco QQQ (QQQ) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
5/12/2025
Today
7/31/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:AKYA
CIK
1711933
Fax
N/A
Employees
90
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$1.08
Potential Upside/Downside
+94.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.97)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$55.37 million
Net Margins
-59.44%
Pretax Margin
-59.28%
Return on Equity
-487.85%
Return on Assets
-35.86%

Debt

Debt-to-Equity Ratio
10.12
Current Ratio
0.61
Quick Ratio
0.40

Sales & Book Value

Annual Sales
$79.96 million
Price / Sales
0.81
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.15 per share
Price / Book
8.60

Miscellaneous

Outstanding Shares
49,954,000
Free Float
46,307,000
Market Cap
$64.44 million
Optionable
Optionable
Beta
1.36
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:AKYA) was last updated on 7/31/2025 by MarketBeat.com Staff
From Our Partners